Satellos Bioscience Inc. (MSCLF)
USD 0.45
(0.0%)
USD 0.45
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -22.06 Million CAD | -1047.21% |
| 2022 | -1.92 Million CAD | 60.51% |
| 2021 | -4.87 Million CAD | -1396.3% |
| 2020 | 375.78 Thousand CAD | 137.96% |
| 2019 | -989.93 Thousand CAD | -9662.69% |
| 2018 | -10.14 Thousand CAD | 99.1% |
| 2017 | -1.12 Million CAD | 52.23% |
| 2016 | -2.36 Million CAD | 13.45% |
| 2015 | -2.72 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -9.83 Million CAD | 25.04% |
| 2024 Q1 | -13.11 Million CAD | 40.57% |
| 2023 Q4 | -22.06 Million CAD | 50.15% |
| 2023 FY | -22.06 Million CAD | -1047.21% |
| 2023 Q3 | -44.26 Million CAD | 5.12% |
| 2023 Q2 | -46.65 Million CAD | -4773.37% |
| 2023 Q1 | -957.26 Thousand CAD | 50.23% |
| 2022 Q4 | -1.92 Million CAD | 38.56% |
| 2022 Q2 | -1.93 Million CAD | 30.44% |
| 2022 Q1 | -2.77 Million CAD | 43.02% |
| 2022 FY | -1.92 Million CAD | 60.51% |
| 2022 Q3 | -3.13 Million CAD | -62.17% |
| 2021 Q2 | -698.33 Thousand CAD | 30.77% |
| 2021 Q1 | -1 Million CAD | -368.41% |
| 2021 Q4 | -4.87 Million CAD | 22.34% |
| 2021 FY | -4.87 Million CAD | -1396.3% |
| 2021 Q3 | -6.27 Million CAD | -798.25% |
| 2020 Q4 | 375.78 Thousand CAD | 0.0% |
| 2020 FY | 375.78 Thousand CAD | 137.96% |
| 2020 Q1 | 399.12 Thousand CAD | 0.0% |
| 2019 FY | -989.93 Thousand CAD | -9662.69% |
| 2018 FY | -10.14 Thousand CAD | 99.1% |
| 2017 FY | -1.12 Million CAD | 52.23% |
| 2016 FY | -2.36 Million CAD | 13.45% |
| 2015 FY | -2.72 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.27 Million USD | 208.833% |
| Skye Bioscience, Inc. | -5.72 Million USD | -285.693% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -250.018% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -8740.237% |
| Qrons Inc. | 351.42 Thousand USD | 6379.256% |
| Adynxx, Inc. | - USD | Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | 593.447% |
| CSL Limited | 10.52 Billion USD | 100.21% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 151.567% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 490.679% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 3574.204% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 150.806% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -108029.165% |
| Rebus Holdings, Inc. | 305 Thousand USD | 7335.082% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -1684403.817% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 3645.674% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 111173.64% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 239.992% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 635.864% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 5591.366% |
| SQZ Biotechnologies Company | -36.23 Million USD | 39.105% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 1084.153% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 2479.997% |
| Mesoblast Limited | 55.85 Million USD | 139.505% |
| Marizyme, Inc. | 18.56 Million USD | 218.838% |
| Genus plc | 190.6 Million USD | 111.578% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 1086.97% |
| Pharming Group N.V. | 109.8 Million USD | 120.097% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 2665.211% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 1917.878% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 3345.147% |
| ContraFect Corporation | -6.02 Million USD | -266.196% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 16489.753% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 2009.853% |
| IMV Inc. | 7.67 Million USD | 387.686% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 501.08% |
| MultiCell Technologies, Inc. | 90.04 USD | 24508096.446% |
| ONE Bio Corp. | 9.04 Million USD | 344.103% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -2906.493% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 270.454% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 1713.119% |
| Q BioMed Inc. | 4.06 Million USD | 643.521% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 172.223% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 2289.803% |
| Biomind Labs Inc. | 711.4 Thousand USD | 3201.903% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 136.447% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 1203.686% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 272.31% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 6234.664% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 15884.241% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 1102.143% |
| GB Sciences, Inc. | 1.74 Million USD | 1362.908% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -11906.769% |
| HST Global, Inc. | 96.79 Thousand USD | 22898.136% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 10800.864% |
| Halberd Corporation | 144.72 Thousand USD | 15347.96% |
| Enzolytics Inc. | 981.65 Thousand USD | 2347.936% |
| Agentix Corp. | 37.63 Thousand USD | 58740.483% |
| Resverlogix Corp. | 6.45 Million USD | 442.071% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -3178.467% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 98.912% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 53.061% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 412.079% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 914.697% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -149.629% |
| AVAX Technologies, Inc. | -5.9 Million USD | -273.814% |
| Zenith Capital Corp. | 10.06 Thousand USD | 219366.693% |
| Genscript Biotech Corporation | -1.06 Billion USD | 97.921% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 11109.719% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 1024.84% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 13513.856% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -120366.208% |
| Kadimastem Ltd | -253.1 Thousand USD | -8618.619% |
| Helix BioMedix, Inc. | -2.57 Million USD | -758.627% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 11064.751% |
| LadRx Corporation | -2.03 Million USD | -983.591% |
| Cell Source, Inc. | 9.23 Million USD | 339.028% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 3574.204% |
| NovAccess Global Inc. | 2.17 Million USD | 1112.961% |
| Affymax, Inc. | -5.59 Million USD | -294.265% |
| Itoco Inc. | 228.3 Thousand USD | 9765.579% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 16327.048% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 545.168% |
| Mobile Lads Corp. | 484.23 Thousand USD | 4657.113% |
| CytoDyn Inc. | 20.26 Million USD | 208.908% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -3410564.606% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -237990.1% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 386.361% |
| SYBLEU INC | 473.71 Thousand USD | 4758.296% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 595.106% |
| International Stem Cell Corporation | 2.59 Million USD | 952.008% |
| Bioxytran, Inc. | 1.89 Million USD | 1262.085% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 35456.416% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 1111.83% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 742.603% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 358.003% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 2956.174% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -1665.36% |
| Neutra Corp. | 52.18 Thousand USD | 42384.477% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -786.581% |
| PureTech Health plc | -167.19 Million USD | 86.802% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -8910.322% |
| IXICO plc | -4.44 Million USD | -396.492% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 266.934% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 140.231% |
| CSL Limited | 10.52 Billion USD | 100.21% |
| Cellectis S.A. | -43.81 Million USD | 49.64% |